ProBioGen and Spica Therapeutics, a biotechnology company advancing pathogenic macrophage subset-targeted immunotherapies, ...

Programmable CRISPR tools are turning stem cell biology into something closer to software engineering, shrinking ...

Four headshots, one of each of the successful ERCC grant winners These highly competitive grants had over 3,000 applicants ...

“We are thrilled to welcome Kathy to Tessera,” said Michael Severino, M.D., CEO. “Her extensive strategic and financial expertise, combined with deep sector knowledge, will be invaluable as we enter ...

The Precision Fermentation Market is expanding rapidly as advancements in synthetic biology, growing consumer preference for sustainable and alternative ...

Four academics at Queen Mary University of London are among 349 researchers to be awarded a prestigious European Research ...

Rocket Pharmaceuticals (NASDAQ:RCKT) advances gene-therapy innovation and appears in broader discussions involving the nasdaq ...

Avant Technologies Inc. ("Avant" or the "Company"), an emerging biotechnology company focused on developing cellbased therapies for diabetes and age-related disorders, today announced a newly ...

Superhero fans can stream the '90s staple Mighty Morphin' Power Rangers, the underrated show Mutant X, and the short-lived ...

Profluent, a leader in frontier AI for protein design, today announced that it has entered into a strategic collaboration with Ensoma, an in vivo cellular engineering company with a mission to advance ...

Microsoft Chairman and CEO Satya Nadella on Tuesday announced an investment of USD 17.5 billion in India to bolster nation’s rapidly growing AI infrastructure ...